PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-08-31
Total Revenue
1,301
786.901
0
Cost of Revenue
-
143.424
-
Gross Profit
-
643.477
-
Operating Expenses
Selling General and Administrative
31,065
29,229
118.605
Total Operating Expenses
33,557
32,446
118.605
Operating Income or Loss
-33,071
-31,803
-118.605
Interest Expense
188.075
173.843
-
Total Other Income/Expenses Net
-1,126
-3,276
-25.79
Income Before Tax
-33,788
-34,667
-144.395
Income from Continuing Operations
-33,788
-34,667
-144.395
Net Income
-33,788
-34,667
-144.395
Net Income available to common shareholders
-33,788
-34,667
-144.395
Basic EPS
-
-0.36
-1.19
Diluted EPS
-
-0.36
-1.19
Basic Average Shares
-
96,050
122.186
Diluted Average Shares
-
96,050
122.186
EBITDA
-
-33,212
-118.605